Skip to main content

Table 3 Overall survival using Cox regression analysis

From: Correlation between overall survival and quality of life in colon cancer patients with chemotherapy

 

Overall survival

 

HR (95.0% CI)

P-value

ICF vs. ICR

2.19 (1.00–4.82)

0.052

SEX(female vs. male)

1.33(0.74–2.38)

0.347

age (≦70 vs.>70 years)

0.98(0.50–1.92)

0.954

site(right vs. left)

0.42(0.17–1.02)

0.054

histology

 well differentiated vs. poorly or undifferentiated

0.47(0.15–1.51)

0.205

 moderately differentiated. vs. poorly or undifferentiated

0.45(0.16–1.31)

0.142

 RAS (wild vs. mutant)

0.55(0.29–1.03)

0.062

ECOG PS

 0 vs. 2

1.85(0.68–5.01)

0.225

 1 vs. 2

1.92(0.79–4.67)

0.149

 liver metastasis (-) vs. (+)

0.66(0.32–1.40)

0.280

 lung metastasis (-) vs. (+)

0.84(0.42–1.67)

0.610

 peritoneal metastasis (-) vs. (+)

0.47(0.17–1.32)

0.152

 Locally advanced tumour (-) vs. (+)

0.27(0.11–0.65)

<0.005*

  1. CI Confidence interval, ECOG Eastern Cooperative Oncology Group, HR Hazard ratio, ICF Inoperable colon cancer at first onset, ICR Inoperable colon cancer at time of relapse, PS Performance status
  2. *<0.05